Investigation Overview
According to a press release a law firm is currently investigating possible violations of the federal securities laws by KV Pharmaceutical Company (NYSE:KV.A / NYSE:KV-A /NYSE:KV-B). According to the press release focuses on allegations that the KV Pharmaceutical Company (NYSE:KV.A / NYSE:KV-A /NYSE:KV-B) did not disclose potential violations of federal regulations and FDA guideli...
You must register (for free) or login to view the entire investigation.